Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fanconi anaemia.

M D Tischkowitz1, S V Hodgson

  • 1Division of Medical and Molecular Genetics, GKT School of Medicine, 8th Floor, Guy's Tower, Guy's Hospital, St Thomas' Street, London SE1 9RT, UK. marc.tischkowitz@kcl.ac.uk

Journal of Medical Genetics
|January 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression and DNA methylation of TNF, IFNG and FOXP3 in colorectal cancer and their prognostic significance.

British journal of cancer·2014
Same author

Opportunities and challenges of next-generation DNA sequencing for breast units.

The British journal of surgery·2014
Same author

A study of genomic instability in early preneoplastic colonic lesions.

Oncogene·2012
Same author

Is colorectal surveillance indicated in patients with PTEN mutations?

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2012
Same author

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families.

British journal of cancer·2012
Same author

TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres.

Gut·2011

Fanconi anaemia (FA) is a genetic disorder causing birth defects and blood cell issues. Early diagnosis and understanding its molecular basis are key for managing FA and associated cancer risks.

Area of Science:

  • Genetics and Molecular Biology
  • Hematology
  • Oncology

Background:

  • Fanconi anaemia (FA) is an inherited condition with characteristic congenital abnormalities, impaired blood formation, and elevated cancer risk.
  • Chromosomal instability, particularly upon exposure to alkylating agents, is a hallmark of FA and informs diagnostic approaches.
  • FA is genetically heterogeneous, resulting from mutations in at least seven different genes.

Purpose of the Study:

  • To review the clinical presentation and natural history of Fanconi anaemia.
  • To discuss current diagnostic methods and management strategies for FA.
  • To integrate recent molecular findings with the cellular and clinical aspects of FA.

Main Methods:

  • Literature review of clinical features, natural history, and molecular genetics of Fanconi anaemia.

Related Experiment Videos

  • Synthesis of information on diagnostic tests, including those based on chromosomal instability.
  • Analysis of established interaction pathways between FA proteins and DNA repair proteins (e.g., ATM, BRCA1/2).

    • Main Results:

    • FA presents with a spectrum of clinical manifestations and is linked to increased risks of acute myeloid leukaemia and solid tumours.
    • Genetic defects in FA involve multiple genes, with established interactions with other DNA repair pathways.
    • Molecular advances provide a deeper understanding of the FA cellular phenotype.

    Conclusions:

    • Fanconi anaemia requires comprehensive management considering its diverse clinical features and genetic underpinnings.
    • Understanding FA's molecular pathways offers insights into DNA repair mechanisms and related diseases.
    • This review consolidates current knowledge on FA, from clinical aspects to molecular mechanisms.